Anti-fibrin antibody binding in valvular vegetations and kidney lesions during experimental endocarditis

Microbiology and Immunology

Volumn 45, Issue 10, 2001, Pages 699-707

  Yokota, M ^a   Basi, D L ^a   Herzberg, M C ^a   Meyer, M W ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Anti fibrin antibody; Endocarditis; Fibrin; Streptococcus sanguinis (sanguis)

Indexed keywords

FIBRIN; FIBRIN ANTIBODY; IMMUNOGLOBULIN G; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN BINDING; AORTA VALVE DISEASE; ARTICLE; BACTERIAL ENDOCARDITIS; CATHETER; HEART LEFT VENTRICLE; KIDNEY INJURY; NONHUMAN; PATHOGENESIS; PROTEIN LOCALIZATION; RABBIT; STREPTOCOCCUS SANGUINIS; VALVULAR HEART DISEASE;

ANIMALS; ANTIBODIES; AORTIC VALVE; DISEASE MODELS, ANIMAL; ENDOCARDITIS, BACTERIAL; FIBRIN; KIDNEY; RABBITS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS SANGUIS; TECHNETIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); ORYCTOLAGUS CUNICULUS; STREPTOCOCCUS SANGUINIS;

EID: 0034758691     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.2001.tb01304.x     Document Type: Article

References (31)

1. Streptococcus mutans-induced nephritis in rabbits
2. 111In-labeled monoclonal anti-fibrin antibody fragments
3. Influence of monocytes and antibiotic treatment on tissue factor activity of endocardial vegetations in rabbits infected with Streptococcus sanguis
4. Role of monocytes and bacteria in Staphylococcus epidermidis endocarditis
5. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: In vitro-in vivo correlations
6. Antithrombotic effect of a monoclonal antibody to the platelet glycoprotein IIb/IIIa receptor in an experimental animal model
7. Predictors of prognosis and risk of acute renal failure in bacterial endocarditis
8. Evaluation of Indium-111-labeled anti-fibrin monoclonal antibody for the diagnosis of venous thrombotic disease
9. Experimental bacterial endocarditis: IV Structure and evaluation of very early lesions
10. Infective and non-infective endocarditis
11. A collagen-like determinant on the surface of Streptococcus sanguis induces platelet aggregation
12. Purification and partial characterization of a 65-kDa platelet aggregation-associated protein antigen of Streptococcus sanguis
13. Cross-reactive immunodeterminants on Streptococcus sanguis and collagen
14. Potential application of labeled antibodies for thrombus detection
15. Phenotypic characterization of Streptococcus sanguis virulence factors associated with bacterial endocarditis
16. The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis
17. Platelet-streptococcal interactions in endocarditis
18. Persistence of infective endocarditis
19. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen
20. New method for labelling of monoclonal antibodies and their fragments with Technetium-99m
21. 111Indium-labeled anti-fibrin antibody for imaging vascular thrombi
22. Fibrinogen, fibrin and crosslinking in aging arterial thrombi
23. Preparation of Fab fragments from IgGs of different species
24. Therapeutic advantage of recombinant human tissue plasminogen activator in endocarditis. Evidence from experiments in rabbits
25. Transport among body compartments
26. Direct labeling of antibodies with Tc-99m
27. Radioimmunoimaging of experimental thrombi in dogs using Technetium-99m-labeled monoclonai antibody fragments reactive with human platelets
28. Dental and cardiac risk factors for infective endocarditis. A population-based, case-control study
29. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy: Simplified preparation and evaluation
30. Infecting microorganisms